Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1776 studies found for:    neoplasms [CONDITION] AND child [AGE-GROUP] | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies
Condition: Myeloid Hematological Malignancies
Interventions: Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Procedure: Cord Blood Stem Cell Infusion
22 Recruiting A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR
Conditions: Solid Tumours;   CNS Tumours
Intervention: Drug: Mitoxantrone packaged EDV (EnGeneIC Delivery Vehicle)
23 Recruiting A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis
Condition: Germ Cell Tumour
Intervention: Drug: Combination Chemotherapy
24 Recruiting Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women
Condition: Breast Cancer
Interventions: Drug: Goserelin;   Drug: Tamoxifen;   Drug: Aromatase Inhibitors
25 Recruiting Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors
Condition: Pediatric Brain Tumors
Intervention: Drug: Hyperpolarized Pyruvate
26 Recruiting A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors
Condition: Relapsed / Recurrent Germ Cell Tumors
Interventions: Drug: Erlotinib;   Drug: Sirolimus
27 Recruiting Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor
Condition: Intracranial Non-germinomatous Germ Cell Tumor
Interventions: Drug: Carboplatin;   Drug: Etoposide;   Drug: Cyclophosphamide;   Drug: Bleomycin;   Drug: Thiotepa;   Drug: Melphalan;   Radiation: Reduced dose radiotherapy
28 Recruiting Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
Conditions: Brain Tumors;   Non-CNS Malignancies
Intervention: Other: Quality of Life surveys completed at specified timepoints
29 Recruiting Laser Interstitial Thermal Therapy (LITT) for the Treatment of Pediatric Central Nervous System Tumors
Condition: Brain Tumor
Intervention: Device: Laser Interstitial Thermotherapy (LITT)
30 Recruiting Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
Conditions: Relapsed Solid Tumors;   Refractory Solid Tumors;   Leukemias
Interventions: Drug: Carfilzomib;   Drug: Cyclophosphamide;   Drug: Etoposide
31 Recruiting Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Condition: Relapsed/Refractory Hematopoietic Malignancies
Intervention: Biological: Tumor associated antigen lymphocytes (TAA-CTL)
32 Recruiting HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
Condition: Supratentorial Neoplasms, Malignant
Intervention: Biological: G207
33 Recruiting Longitudinal Study of Biomarkers
Condition: Central Nervous System Tumor
Intervention:
34 Recruiting Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors
Condition: Central Nervous System Tumors
Interventions: Drug: 25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®);   Drug: 50 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®);   Drug: 100 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®);   Drug: 150 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®);   Drug: 150 mg/m2 Lenalidomide (Revlimid®) and 230 mg/m2 Vorinostat (Zolinza®)
35 Recruiting Project: Every Child for Younger Patients With Cancer
Conditions: Central Nervous System Neoplasm;   Childhood Lymphoma;   Childhood Relapsed Solid Tumor
Intervention: Other: cytology specimen collection procedure
36 Recruiting Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Conditions: Childhood Solid Neoplasm;   Recurrent Central Nervous System Neoplasm;   Refractory Central Nervous System Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Prexasertib
37 Recruiting Metformin in Children With Relapsed or Refractory Solid Tumors
Conditions: Solid Tumors;   Primary Brain Tumors
Interventions: Drug: Vincristine;   Drug: Irinotecan;   Drug: Temozolomide;   Drug: Metformin
38 Not yet recruiting Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Condition: Gestational Trophoblastic Neoplasms
Interventions: Drug: Etoposide;   Drug: actinomycin D;   Drug: methotrexate;   Drug: vincristine;   Drug: cyclophosphamide;   Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Carboplatin
39 Recruiting Neurobehavioral Outcomes and Quality of Life in Pediatric Patients With Brain or Head/Neck Tumors Receiving Proton or Photon Radiotherapy
Condition: Brain Tumor
Intervention: Radiation: standard adjuvant local radiation therapy or cranial radiation therapy
40 Recruiting Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKids
Condition: Metastatic and/or High Risk Solid Tumor of Children
Intervention: Biological: Tumoral specific genetic alterations

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.